FirsthandHealth
medRxiv PreprintsInternational9 November 2026

Plasma phosphorylated tau species across neurodegenerative and cerebrovascular diseases: An ONDRI study

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Elevated plasma phosphorylated tau (p-tau) species are proposed as specific biomarkers of Alzheimer's disease (AD) pathology but have also been reported in amyotrophic lateral sclerosis (ALS). Their profile across neurodegenerative and cerebrovascular diseases, as well as their discriminatory value when combined with other plasma biomarkers, remain uncertain. We studied 551 participants (ages 40.1 to 87.1 years; 207 women), comprising 506 patients from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) multi-site cohort and 45 amyloid-{beta} (A{beta}) PET-negative cognitively un
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.